Wen Guo

Dr. Wen Guo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
YLYang Liu
Yang Liu
XMXiao-Kang Meng
Xiao-Kang Meng
WSWen-Zhen Shao
Wen-Zhen Shao
YLYa-Qun Liu
Ya-Qun Liu
CTChao Tang
Chao Tang
WGWen Guo
Wen Guo

23 August 2024 in Physiology & Behavior
Verified
Journal Article
Closed access
YLYang Liu
Yang Liu
XMXiaokang Meng
Xiaokang Meng
CTChangfa Tang
Changfa Tang
LZLan Zheng
Lan Zheng
KTKun Tao
Kun Tao
WGWen Guo
Wen Guo

28 September 2023 in The FASEB Journal
Verified
Journal Article
Open access
YLYang Liu
Yang Liu
WGWen Guo
Wen Guo
SHSi‐Lu Hong
Si‐Lu Hong
Brain aging is the most important risk factor for neurodegenerative disorders, and abnormal apoptosis is linked to neuronal dysfunction. Specifically, studies have found that exercise effectively inhibits hippocampal neuronal apoptosis, while the molecular mechanism remains unclear. In the present study, we investigated the impact of aerobic exercise on hippocampal neuronal apoptosis in aging mice and the potential involvement of DAPK1 and its downstream pathways based on recent data that DAPK1 may be associated with neuronal death in neurodegenerative diseases. Senescent mice were subjected to 8 weeks of Aerobic training. Following behavioral testing, hippocampal samples were examined histologically and biochemically to detect pathological changes, neuronal apoptosis, and mRNA and protein levels. We found that the exercise intervention improved spatial memory and alleviated neuronal apoptosis in the brain. Notably, exercise down‐regulated DAPK1 expression and inhibited Fas death receptor transactivation and the mitochondrial apoptotic pathway in the hippocampus. These results shed new light on the protective effect of regular exercise against brain aging though modulating the DAPK1 pathway.

27 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DYDong Yang
Dong Yang
WGWen Guo
Wen Guo
LGLiang Guo
Liang Guo
Therapeutic stagnation in Alzheimer’s disease (AD) highlights the role of non-genetic mechanisms like metabolic dysregulation. We propose a paradigm: exercise reprograms phosphoglycerate dehydrogenase (PHGDH) from a pathogenic nuclear transcription factor to a protective cytoplasmic metabolic enzyme through brain-periphery crosstalk. Under AD-associated stress, PHGDH translocate to the nucleus, where its helix-turn-helix (HHTH) domain activates pro-inflammatory genes (e.g., IKKα, HMGB1), suppresses autophagy, and accelerates Aβ deposition. Centrally, exercise-induced myokine irisin suppresses PHGDH nuclear translocation via AMPK/PGC-1α signaling, preserving its metabolic role. Peripherally, exercise inhibits PHGDH in hepatic Kupffer cells, reducing systemic IL-1β release and neuroinflammation. Notably, the HHTH-targeting inhibitor NCT-503 reduces Aβ plaques by 44–62% in APP-KI mice, validating this strategy. This framework positions exercise as a precision intervention, enabling novel diagnostics (e.g., PET probes for PHGDH compartmentalization) and synergistic “exercise-pharmacotherapy.”